Susquehanna International Group
PRNB

Susquehanna International Group’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Susquehanna International Group’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,400
Closed -$442K – 11456
2020
Q2 		$442K Sell
7,400
-12,500
-63% -$772K ﹤0.01% 7631
2020
Q1 		$1.18M Buy
19,900
+15,400
+342% +$898K ﹤0.01% 5017
2019
Q4 		$247K Buy
+4,500
New +$168K ﹤0.01% 8382

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Susquehanna International Group's PRNB Position: Q3 2020 in Review

Susquehanna International Group sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 9,653 shares — an estimated $577K sold.

Susquehanna International Group first reported a position in PRNB in Q2 2019 and held it in 4 quarters. The position peaked at $605K in Q3 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Susquehanna International Group reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Susquehanna International Group sold 9,653 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $577K.
  • Susquehanna International Group first reported a position in Principia Biopharma Inc. Common Stock in Q2 2019 and held it in 4 quarters.
  • Susquehanna International Group's Principia Biopharma Inc. Common Stock position peaked at $605K in Q3 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Susquehanna International Group's 13F filing for Q3 2020, filed 16 Nov 2020.